Tag: gastroesophageal junction cancer

Ipilimumab plus anti-PD-1 therapy is effiective in patients with anti-PD-L1 resistant metastatic melanoma

#VisualAbstract: Chemoradiotherapy plus surgery improves 10-year overall survival compared to surgery alone in esophageal cancer

byTeddy Guo

July 8, 2021

Click to read the study in the Journal of Clinical Oncology.

Nivolumab in resected esophageal or gastroesophageal junction cancer improved survival

byAvneesh Bhanguand1 others

April 5, 2021

1. Adjuvant nivolumab significantly improved disease-free survival compared to placebo among patients with resected esophageal or gastroesophageal junction cancer. 2. ...

Page 2 of 2 Prev 1 2

2 Minute Medicine® is an award winning, physician-run, expert medical media company. Our content is curated, written and edited by practicing health professionals who have clinical and scientific expertise in their field of reporting. Our editorial management team is comprised of highly-trained MD physicians. Join numerous brands, companies, and hospitals who trust our licensed content.

Recent Reports

No Result

View All Result